Antimalarial activity of tigecycline, a novel glycylcycline antibiotic

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 9, 2009, Pages 4040-4042

  Starzengruber, P ^a,b   Thriemer, K ^a,b   Haque, R ^c   Khan, W A ^c   Fuehrer, H P ^a,b   Siedl, A ^a,b   Hofecker, V ^a,b   Ley, B ^a,b   Wernsdorfer, W H ^a   Noedl, H ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MARIB   (Bangladesh)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; DIHYDROARTEMISININ; DOXYCYCLINE; HISTIDINE; HISTIDINE RICH PROTEIN 2; MEFLOQUINE; QUININE; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; BANGLADESH; CONTROLLED STUDY; DRUG SENSITIVITY; IC 50; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMALARIALS; DOXYCYCLINE; INHIBITORY CONCENTRATION 50; MINOCYCLINE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; TETRACYCLINE; TETRACYCLINES;

EID: 70349130353     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00312-09     Document Type: Article

References (17)

1. Agwuh, K. N., and A. MacGowan. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother. 58:256-265.
2. Duraisingh, M. T., P. Jones, I. Sambou, L. von Seidlein, M. Pinder, and D. C. Warhurst. 1999. Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study. Parasitology 119:435-440.
3. Goodman, C. D., V. Su, G. I. and McFadden. 2007. The effects of antibacterials on the malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 152:181-191.
4. Hawkey, P., and R. Finch. 2007. Tigecycline: in-vitro performance as a predictor of clinical efficacy. Clin. Microbiol. Infect. 13:354-362.
5. Muralidharan, G., M. Micalizzi, J. Speth, D. Raible, and S. Troy. 2005. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob. Agents Chemother. 49:220-229.
6. Muralidharan, G., R. J. Fruncillo, M. Micalizzi, D. G. Raible, and S. M. Troy. 2005. Effects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjects. Antimicrob. Agents Chemother. 49:1656-1659.
7. Noedl, H., Y. Se, K. Schaecher, B. L. Smith, D. Socheat, and M. M. Fukuda. 2008. Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359:2619-2620.
8. Noedl, H., B. Attlmayr, W. H. Wernsdorfer, H. Kollaritsch, and R. S. Miller. 2004. A histidine-rich protein 2-based malaria drug sensitivity assay for field use. Am. J. Trop. Med. Hyg. 71:711-714.
9. Noedl, H., J. Bronnert, K. Yingyuen, B. Attlmayr, H. Kollaritsch, and M. Fukuda. 2005. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob. Agents Chemother. 49:3575-3577.
10. Noedl, H., W. H. Wernsdorfer, R. S. Miller, and C. Wongsrichanalai. 2002. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob. Agents Chemother. 46:1658-1664.
11. Noedl, H., S. Krudsood, W. Leowattana, N. Tangpukdee, W. Thanachartwet, S. Looareesuwan, R. R. Miller, M. Fukuda, K. Jongsakul, K. Yingyuen, S. Sriwichai, C. Ohrt, and C. Knirsch. 2007. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob. Agents Chemother. 51:651-656.
12. Pradines, B., A. Spiegel, C. Rogier, A. Tall, J. Mosnier, T. Fusai, J. F. Trape, and D. Parzy. 2000. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. Am. J. Trop. Med. Hyg. 62:82-85.
13. Ramharter, M., H. Noedl, H. Winkler, W. Graninger, W. H. Wernsdorfer, P. G. Kremsner, and S. Winkler. 2003. In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Antimicrob. Agents Chemother. 47:3494-3499. (Pubitemid 37345709)
14. Sponer, U., S. Prajakwong, G. Wiedermann, H. Kollaritsch, G. Wernsdorfer, and W. H. Wernsdorfer. 2002. Pharmacodynamic interaction of doxycycline and artemisinin in Plasmodium falciparum. Antimicrob. Agents Chemother. 46:262-264.
15. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:209-218.
16. World Health Organisation. 2006. Guidelines for the treatment of malaria. http://www.who.int/malaria/treatmentguidelines.html. Accessed 2 February 2009.
17. Zhanel, G. G., K. Homenuik, K. Nichol, A. Noreddin, L. Vercaigne, J. Embil, A. Gin, J. A. Karlowsky, and D. J. Hoban. 2004. The glycylcyclines: a comparative review with the tetracyclines. Drugs 64:63-88.